Maeve Duffy

Maeve Duffy has almost 20 years of experience in the pharmaceutical industry working in a variety of roles ranging from Clinical Project Manager, Head/Director of Clinical Operations through to Head of Clinical Development. From 2010 to 2018 Maeve worked at the UK biotech company Proximagen, latterly as Head of Clinical Development. In this role, she was responsible for the development of a compound for OA pain, which was partnered with Roche. Maeve led the cross-company project team and was a member of the Joint Steering Committee. Maeve also led QA activities for Proximagen. Previously, Maeve held clinical positions within the biotech companies Serentis and Arakis and at the CRO ICON Clinical Research. Maeve has a BSc in pharmacology and a PhD in biochemistry from University College Dublin.